• 2024
  Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Winheim E, Schuster EM, Dobler G, Hoelscher M, Kümmerer BM, Endres S, Schober K, Krug AB, Pritsch M, Barba-Spaeth G, Rothenfusser S, Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection., Nat Commun 2024 Feb; 15(1): 1696.
• 2023
  E. Crampon, E. Covernton, M. Vaney, M. Dellarole, S. Sommer, A. Sharma, Ahmed Haouz, Patrick England, J. Lepault, S. Duquerroy, F. Rey, Giovanna Barba-Spaeth, New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complex, mBio, In press, ⟨10.1128/mbio.00706-23⟩.
• 2023
  Yann Aquino, Aurélie Bisiaux, Zhi Li, Mary O'Neill, Javier Mendoza-Revilla, Sarah Hélène Merkling, Gaspard Kerner, Milena Hasan, Valentina Libri, Vincent Bondet, Nikaïa Smith, Camille de Cevins, Mickaël Ménager, Francesca Luca, Roger Pique-Regi, Giovanna Barba-Spaeth, Stefano Pietropaoli, Olivier Schwartz, Geert Leroux-Roels, Cheuk-Kwong Lee, Kathy Leung, Joseph Wu, Malik Peiris, Roberto Bruzzone, Laurent Abel, Jean-Laurent Casanova, Sophie Valkenburg, Darragh Duffy, Etienne Patin, Maxime Rotival, Lluis Quintana-Murci, Dissecting human population variation in single-cell responses to SARS-CoV-2, Nature, 2023, 53 (8), pp.e2250307. ⟨10.1038/s41586-023-06422-9⟩.
• 2023
  Isnard P, Vergnaud P, Garbay S, Jamme M, Eloudzeri M, Karras A, Anglicheau D, Galantine V, Jalal Eddine A, Gosset C, Pourcine F, Zarhrate M, Gibier JB, Rensen E, Pietropaoli S, Barba-Spaeth G, Duong-Van-Huyen JP, Molina TJ, Mueller F, Zimmer C, Pontoglio M, Terzi F, Rabant M, A specific molecular signature in SARS-CoV-2-infected kidney biopsies., JCI Insight 2023 Mar; 8(5): .
• 2023
  Sokal A, Bastard P, Chappert P, Barba-Spaeth G, Fourati S, Vanderberghe A, Lagouge-Roussey P, Meyts I, Gervais A, Bouvier-Alias M, Azzaoui I, Fernández I, de la Selle A, Zhang Q, Bizien L, Pellier I, Linglart A, Rothenbuhler A, Marcoux E, Anxionnat R, Cheikh N, Léger J, Amador-Borrero B, Fouyssac F, Menut V, Goffard JC, Storey C, Demily C, Mallebranche C, Troya J, Pujol A, Zins M, Tiberghien P, Gray PE, McNaughton P, Sullivan A, Peake J, Levy R, Languille L, Rodiguez-Gallego C, Boisson B, Gallien S, Neven B, Michel M, Godeau B, Abel L, Rey FA, Weill JC, Reynaud CA, Tangye SG, Casanova JL, Mahévas M, , Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination., J Exp Med 2023 Jan; 220(1): .
• 2022
  Pepe A, Pietropaoli S, Vos M, Barba-Spaeth G, Zurzolo C, , Tunneling nanotubes provide a route for SARS-CoV-2 spreading., Sci Adv 2022 Jul; 8(29): eabo0171.
• 2022
  Sokal A, Broketa M, Barba-Spaeth G, Meola A, Fernández I, Fourati S, Azzaoui I, de La Selle A, Vandenberghe A, Roeser A, Bouvier-Alias M, Crickx E, Languille L, Michel M, Godeau B, Gallien S, Melica G, Nguyen Y, Zarrouk V, Canoui-Poitrine F, Noizat-Pirenne F, Megret J, Pawlotsky JM, Fillatreau S, Simon-Lorière E, Weill JC, Reynaud CA, Rey FA, Bruhns P, Chappert P, Mahévas M, , Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant., Immunity 2022 Jun; 55(6): 1096-1104.e4.
• 2022
  Rensen E, Pietropaoli S, Mueller F, Weber C, Souquere S, Sommer S, Isnard P, Rabant M, Gibier JB, Terzi F, Simon-Loriere E, Rameix-Welti MA, Pierron G, Barba-Spaeth G, Zimmer C, Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH., Life Sci Alliance 2022 Apr; 5(4): .
• 2022
  Scheck MK, Lehmann L, Zaucha M, Schwarzlmueller P, Huber K, Pritsch M, Barba-Spaeth G, Thorn-Seshold O, Krug AB, Endres S, Rothenfusser S, Thorn-Seshold J, , FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D., PLoS One 2022 ; 17(2): e0262149.
• 2021
  Sokal A, Barba-Spaeth G, Fernández I, Broketa M, Azzaoui I, de La Selle A, Vandenberghe A, Fourati S, Roeser A, Meola A, Bouvier-Alias M, Crickx E, Languille L, Michel M, Godeau B, Gallien S, Melica G, Nguyen Y, Zarrouk V, Canoui-Poitrine F, Pirenne F, Mégret J, Pawlotsky JM, Fillatreau S, Bruhns P, Rey FA, Weill JC, Reynaud CA, Chappert P, Mahévas M, , mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants., Immunity 2021 Dec; 54(12): 2893-2907.e5.
• 2021
  Rezelj VV, Carrau L, Merwaiss F, Levi LI, Erazo D, Tran QD, Henrion-Lacritick A, Gausson V, Suzuki Y, Shengjuler D, Meyer B, Vallet T, Weger-Lucarelli J, Bernhauerová V, Titievsky A, Sharov V, Pietropaoli S, Diaz-Salinas MA, Legros V, Pardigon N, Barba-Spaeth G, Brodsky L, Saleh MC, Vignuzzi M, , Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts., Nat Commun 2021 Apr; 12(1): 2290.
• 2021
  Sokal A, Chappert P, Barba-Spaeth G, Roeser A, Fourati S, Azzaoui I, Vandenberghe A, Fernandez I, Meola A, Bouvier-Alias M, Crickx E, Beldi-Ferchiou A, Hue S, Languille L, Michel M, Baloul S, Noizat-Pirenne F, Luka M, Mégret J, Ménager M, Pawlotsky JM, Fillatreau S, Rey FA, Weill JC, Reynaud CA, Mahévas M, , Maturation and persistence of the anti-SARS-CoV-2 memory B cell response., Cell 2021 Mar; 184(5): 1201-1213.e14.
• 2020
  Huber JE, Ahlfeld J, Scheck MK, Zaucha M, Witter K, Lehmann L, Karimzadeh H, Pritsch M, Hoelscher M, von Sonnenburg F, Dick A, Barba-Spaeth G, Krug AB, Rothenfußer S, Baumjohann D, , Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination., Clin Transl Immunology 2020 May; 9(5): e1129.
• 2020
  Wec AZ, Haslwanter D, Abdiche YN, Shehata L, Pedreño-Lopez N, Moyer CL, Bornholdt ZA, Lilov A, Nett JH, Jangra RK, Brown M, Watkins DI, Ahlm C, Forsell MN, Rey FA, Barba-Spaeth G, Chandran K, Walker LM, , Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine., Proc Natl Acad Sci U S A 2020 Mar; 117(12): 6675-6685.
• 2017
  Rouvinski A, Dejnirattisai W, Guardado-Calvo P, Vaney MC, Sharma A, Duquerroy S, Supasa P, Wongwiwat W, Haouz A, Barba-Spaeth G, Mongkolsapaya J, Rey FA, Screaton GR, , Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope., Nat Commun 2017 May; 8(): 15411.
• 2016
  Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel MP, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M, , Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses., J Virol 2016 Nov; 90(21): 9683-9692.
• 2016
  Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau VM, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR, , Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus., Nat Immunol 2016 Sep; 17(9): 1102-8.
• 2016
  Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Lorière E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA, , Structural basis of potent Zika-dengue virus antibody cross-neutralization., Nature 2016 Aug; 536(7614): 48-53.
• 2015
  Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney MC, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, Girard-Blanc C, Petres S, Shepard WE, Desprès P, Arenzana-Seisdedos F, Dussart P, Mongkolsapaya J, Screaton GR, Rey FA, , Recognition determinants of broadly neutralizing human antibodies against dengue viruses., Nature 2015 Apr; 520(7545): 109-13.
• 2011
  Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F, , Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia., J Immunol 2011 May; 186(10): 5590-602.
• 2010
  Stoyanov CT, Boscardin SB, Deroubaix S, Barba-Spaeth G, Franco D, Nussenzweig RS, Nussenzweig M, Rice CM, , Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii., Vaccine 2010 Jun; 28(29): 4644-52.
• 2006
  Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR, Rice CM, , Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics., Gastroenterology 2006 Dec; 131(6): 1887-98.
• 2005
  Barba-Spaeth G, Longman RS, Albert ML, Rice CM, , Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes., J Exp Med 2005 Nov; 202(9): 1179-84.
• 2005
  Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice CM, Nussenzweig RS, , Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model., J Exp Med 2005 Jan; 201(2): 201-9.
• 2002
  Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G, Bréchot C, , Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis., FASEB J 2002 Feb; 16(2): 185-94.
• 1999
  Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, Matsuura Y, Miyamura T, Bréchot C, Barba G, , Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates., Hepatology 1999 Oct; 30(4): 1064-76.
• 1999
  Loriot MA, Bronowicki JP, Lagorce D, Lakehal F, Persico T, Barba G, Mergey M, Vons C, Franco D, Belghiti J, Giacca M, Housset C, Bréchot C, , Permissiveness of human biliary epithelial cells to infection by hepatitis C virus., Hepatology 1999 May; 29(5): 1587-95.
• 1997
  Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Bréchot C, , Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets., Proc Natl Acad Sci U S A 1997 Feb; 94(4): 1200-5.
• 1994
  Barba GM, Braun-Heimer L, Rittner C, Schneider PM, , A new PCR-based typing of the Rodgers and Chido antigenic determinants of the fourth component of human complement., Eur J Immunogenet 1994 Oct; 21(5): 325-39.
• 1994
  Barba GM, Kaufmann TJ, Schneider PM, Rittner C, Brai M, , Polymorphism of the complement C8A and -B genes in two families with C8 beta deficiency and neisserial infections., Clin Immunol Immunopathol 1994 Jul; 72(1): 83-9.
• 1993
  Barba G, Rittner C, Schneider PM, , Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression., J Clin Invest 1993 Apr; 91(4): 1681-6.
• 1990
  Giallongo A, Oliva D, Calì L, Barba G, Barbieri G, Feo S, , Structure of the human gene for alpha-enolase., Eur J Biochem 1990 Jul; 190(3): 567-73.
• 1990
  Feo S, Oliva D, Arico B, Barba G, Cali L, Giallongo A, , The human genome contains a single processed pseudogene for alpha enolase located on chromosome 1., DNA Seq 1990 ; 1(1): 79-83.